Blog
Is Alexion Pharmaceuticals a Buy?
There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ: ALXN), a developer of treatments for rare diseases
Is Cresco Labs Stock in Trouble?
Cresco Labs (OTC: CRLBF) was likely expecting 2020 to be a strong year not just for itself but for the cannabis industry as a whole. With more states -- including its home base of Illinois --
Why Peloton Is Pedaling Uphill
The coronavirus pandemic has millions of us holed up at home with little physical contact to the outside world. Companies like Peloton Interactive Inc. (NASDAQ: PTON), which manufactures home
Dave & Buster's Has Slashed Cash Outflow to Below $10 Million per Week
Dave & Buster's Entertainment (NASDAQ: PLAY) recently announced preliminary fiscal fourth-quarter results that continued the mixed trends that investors have seen for over a year. Comparable-store
Working From Home Could Become a Long-Term Trend, Data Shows
The option to work from home is usually considered a privilege, but during the COVID-19 crisis, it's become a necessity. And many employees are learning the hard way that doing their jobs remotely
3 Pot Stocks to Avoid as the Coronavirus Pandemic Continues
Even before the coronavirus pandemic, most cannabis companies were struggling to get a grip on their financial situations. Whether the issue was continued losses, increasing inventory buildups, or
Why Canadian Pot Stocks Are Safer Than Their U.S. Counterparts in the Coronavirus Market Crash
There's one very significant difference between the marijuana industry in Canada and the U.S.: legality. In Canada, recreational pot's been legal nationwide since Oct. 17, 2018. In the U.S., only 11
1 Financial Disaster That Happened To Me, But You Can Avoid
Money mistakes can take a long time to recover from, which is unfortunate because they're easy to make. I know this from personal experience because when I was going to school, I made a serious
Where Will Vertex Pharmaceuticals Be in 1 Year?
Vertex Pharmaceuticals (NASDAQ: VRTX), a leader in the treatment of cystic fibrosis, has expanded its annual revenue over the past five years, and its latest approved drug likely will help it keep
Elon Musk Wants Taxpayers to Pay for His Starlink Satellites
Coronavirus be ... darned, SpaceX continues to build its Starlink satellite internet business.
On March 18, in the midst of the pandemic, SpaceX successfully launched its sixth batch of Starlink
Can Zoom Video Communications Counter This Chinese Tech Giant?
Shares of Zoom Video Communications (NASDAQ: ZM) have surged more than 75% this year as the COVID-19 pandemic boosted usage of its videoconferencing and remote collaboration tools. However, Zoom
3 High-Growth Stocks That Could Soar
In the midst of the fallout from the coronavirus, it's difficult to envision a time when the outbreak is under control and life has returned to normal. But those days are coming. That said
Don't Tap Your Retirement Savings Without Reading This
Millions of Americans are out of work indefinitely due to COVID-19, and that has a lot of people scrambling to figure out how to provide for their families until life returns to normal. Unemployment
Should Investors Take a Chance on Biogen?
Earlier this year, Biogen (NASDAQ: BIIB) dodged a bullet when it won a patent challenge to its multiple sclerosis (MS) drug, Tecfidera, in a lawsuit brought before the U.S. Patent Trial and Appeal
50% of Americans Say Their Savings Will Run Out This Month
The COVID-19 outbreak has spurred not just a health crisis, but also an economic one. With millions of Americans now out of work and countless small businesses shut down, a large number of U.S
Here's Why Intuitive Surgical is the Tesla of the Healthcare Industry
Few stocks have captured investors' imaginations quite like Tesla (NASDAQ: TSLA). A unique blend of the tech and automotive industries, the electric car maker has grown more than 3,200% since its
3 Social Security Mistakes That Could Cost You a Fortune
About two-thirds of Americans worry about the Social Security system, as it's supposed to start running a deficit soon -- and fully 41% worry a great deal, per a 2019 Gallup poll. In 2015, about
Is AnaptysBio Stock a Buy?
AnaptysBio (NASDAQ: ANAB) checks many boxes that make it an attractive biotech investment: It's got a sizable cash position, reputable pharma partners, and a promising drug pipeline. Throw in a
Up to 65 Million People Won't Receive a Trump Stimulus Check -- Here's Why
What we're witnessing now with regard to the coronavirus disease 2019 (COVID-19) and the global response to mitigate its spread is without precedent.
As recently as six weeks ago, the idea of
Is Hartford Financial Services Stock a Buy?
Hartford Financial Services Group (NYSE: HIG), better known as The Hartford, had a good year in 2019, returning a market-beating 36.7% -- but 2020 has been a much stiffer challenge. The coronavirus
Got $2,500? Park It in These 4 Stocks for the Next 20 Years
For investors, the past seven weeks have been unmatched in terms of volatility. Uncertainties surrounding the spread of the coronavirus disease 2019 (COVID-19), as well as the stringent mitigation
Shaw Communications Inc (SJR) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool.
Shaw Communications Inc (NYSE: SJR)Q2 2020 Earnings CallApr 9, 2020, 4:30 p.m. ET
Operator
Source Fool.com
WD-40 Co (WDFC) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool.
WD-40 Co (NASDAQ: WDFC)Q2 2020 Earnings CallApr 9, 2020, 5:00 p.m. ET
Operator
Source Fool.com
Simulations Plus Inc (SLP) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool.
Simulations Plus Inc (NASDAQ: SLP)Q2 2020 Earnings CallApr 9, 2020, 4:15 p.m. ET
Operator
Source Fool.com
Citigroup Promoting Offering Automatic Promotion to Full-Time for Most Intern Graduates
Citigroup (NYSE: C) is bolstering its ranks by offering full-time positions to many of its current interns, a spokesman for the big banking conglomerate said on Thursday. The current crop of interns


